Amgen reports lower profit, flat sales

Amgen reports a lower third-quarter profit late Monday, due in part to decreased sales of its anemia drugs Aranesp and Epogen.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.